Astera Labs, Inc. Common Stock
Here’s whether Astera Labs, Inc. Common Stock (ALAB) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); strong 1-year return of +196.1%; rising volume confirms the move (1.19x 30d avg). Concerns: 50-day MA is falling (-1.79% over 10 days); RSI 82 — overbought, elevated pullback risk. Currently 33.8% off its 52-week high. Score: +3/7.
ALAB is in a confirmed uptrend, trading above both its 50-day ($131.16) and 200-day ($157.75) moving averages. With an RSI of 82.4, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +196.1% compares to +35.1% for SPY (beat the market by 161.0%). The current 33.8% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.